PhotoMedex, Inc. (NasdaqGS: PHMD) today announced that Dennis McGrath, president and chief financial officer, will present at the Maxim Group Growth Conference on Monday, March 26 at 10:30 a.m. Eastern Time. The presentation will provide a corporate overview and a discussion of the Company’s growth strategy. The conference will be held at The Grand Hyatt Hotel, Grand Central Station, New York, on March 26, 2012.
Management will be available for one-on-one meetings with the investment community during the conference. Please contact Maxim conference organizers or Kim Sutton Golodetz of LHA, Inc., email@example.com if you would like to arrange a meeting.
Interested parties can access the audio webcast with slide presentation at www.photomedex.com. An archived presentation will be available for 30 days.
About PhotoMedexPhotoMedex is a global skin health company providing integrated disease management and aesthetic solutions to dermatologists, professional aestheticians and consumers. The company provides proprietary products and services that address skin diseases and conditions including psoriasis, vitiligo, acne, actinic keratosis (a precursor to certain types of skin cancer) and photo damage. Its experience in the physician market provides the platform to expand its skin health solutions to spa markets, as well as traditional retail, online and infomercial outlets for home-use products. As a result of its December 2011 merger with Radiancy Inc., PhotoMedex has added a range of home-use devices under the no!no!™ brand, for various indications including hair removal, acne treatment and skin rejuvenation. The company also offers a professional product line for acne clearance, skin tightening, psoriasis care and hair removal sold to physician clinics and spas.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts